Avanos Medical, Inc.AVNSNYSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank57
3Y CAGR+6.7%
5Y CAGR+1.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+6.7%/yr
vs +2.6%/yr prior
5Y CAGR
+1.7%/yr
Recent acceleration
Acceleration
+4.1pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $352.20M | +14.9% |
| 2024 | $306.50M | +4.4% |
| 2023 | $293.60M | +1.3% |
| 2022 | $289.90M | -20.5% |
| 2021 | $364.70M | +12.5% |
| 2020 | $324.20M | +9.7% |
| 2019 | $295.40M | +13.0% |
| 2018 | $261.40M | -4.8% |
| 2017 | $274.70M | +2.1% |
| 2016 | $269.00M | - |